GlassScriptPhysician profile
Valery D Tarasenko
NPI 1912981713
$9,206.36
in general payments reported to CMS, 2019-2025
51 companies · $1,083 in 2025
The $1,083 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,864 · 2020: $729 · 2021: $959 · 2022: $1,096 · 2023: $1,423 · 2024: $2,052 · 2025: $1,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,754 · Travel and Lodging: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,754.27 |
| Travel and Lodging | $803.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,557.34 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Si-Bone, INC. | $1,014.96 | 2019-2024 | |
| Nevro Corp. | $610.51 | 2019-2022 | |
| Boston Scientific Corporation | $575.40 | 2021-2025 | Infinion 16, Wavewriter Alpha Prime 16, Clik X |
| Collegium Pharmaceutical, INC. | $351.53 | 2020-2025 | Xtampza, Belbuca |
| Allergan, INC. | $340.41 | 2019-2022 | |
| Medtronic, INC. | $325.65 | 2021-2023 | Intellis Adaptivestim |
| Indivior INC. | $296.82 | 2019-2020 | |
| Mdd US Operations, LLC | $273.37 | 2019-2020 | |
| Fidia Pharma USA INC. | $245.42 | 2024-2025 | Hyalgan |
| Pfizer INC. | $243.97 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $236.21 | 2022-2025 | Ztlido |
| Biodelivery Sciences International, INC. | $212.73 | 2019-2020 | |
| Merz North America, INC. | $210.30 | 2019-2020 | |
| Orexo US, INC. | $190.43 | 2019-2020 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valery Tarasenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.